Analystreport

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating. They now have a $70.00 price t

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com